LGC Clinical Diagnostics | SeraCare is delighted to announce the expansion of our oncology portfolio with the release of our Seraseq® Unmethylated ctDNA Mutation Mix (0710-3088) and Seraseq® Methylated ctDNA Mutation Mix (0710-3089). Being the only solution of its kind available on the market, our methylated ctDNA product offering introduces a first-in-class ctDNA that is fully methylated for assay development, validation, and routine performance monitoring.
Inspire confidence in your ctDNA methylation assay today with a low-noise ctDNA format methylation reference material. Order today!
Key Features
- Global methylation of CpG sites to support all CpG methylation assays
- Unmethylated ctDNA and Methylated ctDNA to blend to a desired percent methylated ctDNA
- Enzymatically fragmented ctDNA for low background noise and physiologically relevant fragment sizes
- Methylation status is precisely quantified using highly sensitive digital PCR assays in a well-characterized genomic background (GM24385)
- Validated by targeted NGS panels
- Manufactured in GMP-compliant, ISO 13485-certified facilities
Take a look at our latest solutions and discover how they can transform test results. Our team of experts is always on hand to provide guidance and support, ensuring that you get the most out of our products. Email CDx-Sales@lgcgroup.com or call 1-800-676-1881.